Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (AVHHL) Exchange Rate Effect (2019 - 2023)

AVITA Medical posted quarterly Exchange Rate Effect of -$1000.0 for Q4 2023, down 102.27% year-on-year from $44000.0 in Q4 2022, and up 94.44% on a QoQ basis from -$18000.0 in Q3 2023.

AVITA Medical (AVHHL) has 5 years of Exchange Rate Effect data on file, last reported at -$1000.0 in Q4 2023.

  • For the quarter ending Q4 2023, Exchange Rate Effect fell 102.27% year-over-year to -$1000.0; the trailing twelve-month figure through Dec 2023 stood at -$16000.0 (up 50.0% YoY), and the FY2023 full-year result was -$16000.0, up 38.46% from the prior year.
  • Exchange Rate Effect for Q4 2023 stood at -$1000.0, up from -$18000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $127000.0 in Q3 2020 and bottomed at -$68000.0 in Q1 2020.
  • The 5-year median for Exchange Rate Effect is -$3500.0 (2022), against an average of $4071.4.
  • The widest annual swing landed in 2020, when Exchange Rate Effect surged 677.27%; it then tumbled 143.31% in 2021.
  • A 5-year view of Exchange Rate Effect shows it stood at $48000.0 in 2019, then slumped by 35.42% to $31000.0 in 2020, then sank by 277.42% to -$55000.0 in 2021, then surged by 180.0% to $44000.0 in 2022, then sank by 102.27% to -$1000.0 in 2023.
  • The last three Exchange Rate Effect figures came in at -$1000.0 (Q4 2023), -$18000.0 (Q3 2023), and $2000.0 (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -23.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -19.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 24.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 8.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 45.66 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -2.80 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -37.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -4.40 Mn
10 AVITA Medical - - 14.31 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 -1,000.00
Dec 31, 2023 -1,000.00
Sep 30, 2023 -18,000.00
Sep 30, 2023 -18,000.00
Jun 30, 2023 2,000.00
Jun 30, 2023 2,000.00
Mar 31, 2023 1,000.00
Mar 31, 2023 1,000.00
Dec 31, 2022 44,000.00
Dec 31, 2022 44,000.00
Mar 31, 2022 -6,000.00
Mar 31, 2022 -6,000.00
Sep 30, 2021 -55,000.00
Sep 30, 2021 -55,000.00
Jun 30, 2021 -15,000.00
Jun 30, 2021 -15,000.00
Mar 31, 2021 -11,000.00
Mar 31, 2021 -11,000.00
Dec 31, 2020 31,000.00
Dec 31, 2020 31,000.00
Sep 30, 2020 127,000.00
Sep 30, 2020 127,000.00
Mar 31, 2020 -68,000.00
Mar 31, 2020 -68,000.00
Dec 31, 2019 48,000.00
Dec 31, 2019 48,000.00
Sep 30, 2019 -22,000.00
Sep 30, 2019 -22,000.00